Journal article icon

Journal article

Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study.

Abstract:

BACKGROUND AND AIMS: The benefit of 5-aminosalicylic acid therapy for maintenance of remission in Crohn's disease is controversial. The primary aim of this study was to evaluate the prophylactic properties of olsalazine in comparison with placebo for maintenance of remission in quiescent Crohn's colitis and/or ileocolitis. METHODS: In this randomised, double blind, parallel group study of olsalazine versus placebo, 328 patients with quiescent Crohn's colitis and/or ileocolitis were recruited....

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1136/gut.49.4.552

Authors


Jewell, DP More by this author
O'Morain, CA More by this author
Expand authors...
Journal:
Gut
Volume:
49
Issue:
4
Pages:
552-556
Publication date:
2001-10-05
DOI:
EISSN:
1468-3288
ISSN:
0017-5749
URN:
uuid:374b2f7b-a87b-44c1-abbe-d544b124acee
Source identifiers:
135778
Local pid:
pubs:135778

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP